To the full analysis
Nutrien stock: growth
NTRNutrien reported $26.89B in revenue for fiscal 2025, up 3.5% on the prior year, up 5.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.9%
per year from 2006 to 2025, per share 9.4%
Earnings (Annual rate)
7%
per year from 2006 to 2025, per share 5.6%
Free cash flow (Annual rate)
13.4%
per year from 2006 to 2025, per share 11.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 5.2% | 15.7% | 10.9% |
| Revenue per share | 8.5% | 11.4% | 9.4% |
| Earnings | 37.6% | 6.0% | 7.0% |
| Earnings per share | 41.0% | 2.2% | 5.6% |
| Free cash flow | 2.8% | 6.2% | 13.4% |
| Free cash flow per share | 6.1% | 2.2% | 11.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $3.77B | $631.8M | $188.2M |
| 2007 | $5.23B | $1.1B | $1.08B |
| 2008 | $9.45B | $3.5B | $1.77B |
| 2009 | $3.98B | $987.8M | −$894M |
| 2010 | $6.54B | $1.81B | $1.05B |
| 2011 | $8.72B | $3.08B | $1.31B |
| 2012 | $7.93B | $2.08B | $1.09B |
| 2013 | $7.31B | $1.79B | $1.59B |
| 2014 | $7.12B | $1.54B | $1.48B |
| 2015 | $6.28B | $1.27B | $1.12B |
| 2016 | $4.46B | $336M | $367M |
| 2017 | $4.55B | $327M | $574M |
| 2018 | $19.64B | $3.57B | $545M |
| 2019 | $20.08B | $992M | $1.77B |
| 2020 | $20.91B | $459M | $1.77B |
| 2021 | $27.71B | $3.15B | $2B |
| 2022 | $37.88B | $7.66B | $5.64B |
| 2023 | $29.06B | $1.26B | $2.47B |
| 2024 | $25.97B | $674M | $1.38B |
| 2025 | $26.89B | $2.27B | $2.04B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 8 Aug 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.